DUBLIN–(BUSINESS WIRE)-The “Cannabis Pharmaceuticals Market Research Report by Brand, By Product Type, By Distribution Channel, By Application, By State – US Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to from ResearchAndMarkets.com offer.
The US Pharmaceutical Cannabis Market size was estimated at USD 168.41 Million in 2020, is projected to reach USD 209.88 Million in 2021 and is projected to grow at a CAGR of 21.21% to reach USD 647.53 Million by 2027.
In this report, the years 2018 and 2019 are considered as historical years, 2020 as the base year, 2021 as the estimated year and the years from 2022 to 2027 as the forecast period.
Cumulative impact of COVID-19:
The report provides insights into COVID-19 considering shifts in consumer behavior and demand, shopping patterns, supply chain rerouting, current market force dynamics, and significant interventions governments. The updated study provides insights, analysis, estimates, and forecasts considering the impact of COVID-19 on the market.
Competitive Strategy Window:
The strategic competitive window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or match between its capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for vendors to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to execute further business expansion and growth. during a forecast period.
FPNV positioning matrix:
The FPNV Positioning Matrix evaluates and ranks vendors in the cannabis pharmaceuticals market based on business strategy (business growth, industry coverage, financial viability, and channel support) and product satisfaction (value for money, ease of use, product features, and customer support) that helps businesses make better decisions and better understand the competitive landscape.
Market share analysis:
The market share analysis offers the analysis of the vendors considering their contribution to the overall market. It gives the idea of its revenue generation in the overall market compared to other providers in the space.
It provides information on the performance of vendors in terms of revenue generation and customer base compared to others. Knowing the market share gives an idea of the size and competitiveness of suppliers for the reference year. It reveals the characteristics of the market in terms of accumulation, fragmentation, dominance and merger.
Enterprise Usability Profiles:
The report thoroughly explores significant recent developments by key vendors and innovation profiles in the U.S. Cannabis Pharmaceuticals Market, including
-
AbbVie Inc.
-
Amyris, Inc.
-
Aphria, Inc.
-
Aurora Cannabis Inc.
-
Botanix Pharmaceuticals
-
Breath of Life Pharma, Ltd.
-
Cannabis Science, Inc.
-
Canopy Growth Society
-
Therapeutic Cara
-
CB Therapeutics Inc.
-
Corbus Pharmaceuticals Holdings, Inc.
-
Cronos Group Inc.
-
GW Pharmaceuticals, PLC
-
Insys Therapeutics, Inc.
-
Medical Marijuana Inc.
-
Pharmaceutical Medicine
-
MedReleaf Corp.
-
MGC Pharmaceuticals Limited
-
Pascal Biosciences Inc.
-
PharmaCyte Biotech, Inc.
-
Serina Therapeutics, Inc.
-
Teva Pharmaceutical Industries Ltd.
-
Tilray, Inc.
-
Valiant Pharmaceuticals
-
Zynerba Pharmaceuticals, Inc.
Main topics covered:
1. Preface
1.1. Study objectives
1.2. Market segmentation and coverage
1.3. Years Considered for Study
1.4. Currency and price
1.5. Language
1.6. Limits
1.7. Hypotheses
1.8. Stakeholders
2. Research methodology
2.1. introduction
2.2. Define: research objective
2.3. Determine: research design
2.4. Prepare: finding aid
2.5. Collect: Data Source
2.6. Analysis: Interpretation of data
2.7. Formula: data verification
2.8. Publish: Research Report
2.9. Repeat: report update
3. Executive Summary
4. Market Overview
5. Market Overview
5.1. Market dynamics
5.1.1. Drivers
5.1.2. Constraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative impact of COVID-19
6. Cannabis Pharmaceuticals Market, By Brand
6.1. introduction
6.2. Epidiolex
6.3. Sativex
7. Cannabis Pharmaceuticals Market, By Product Type
7.1. introduction
7.2. Ointments & Creams
7.3. Solid and soluble powder and oil
8. Cannabis Pharmaceuticals Market, By Distribution Channel
8.1. introduction
8.2. Hospital pharmacies
8.3. Online pharmacies
8.4. Retail pharmacies
9. Pharmaceutical Cannabis Products Market, By Application
9.1. introduction
9.2. Arthritis
9.3. Cancer
9.4. Epilepsy
9.5. Migraine
10. California Cannabis Pharmaceuticals Market
11. Florida Cannabis Pharmaceuticals Market
12. Illinois Cannabis Pharmaceuticals Market
13. Cannabis Pharmaceuticals Market in New York
14. Ohio Pharmaceutical Cannabis Market
15. Pennsylvania Cannabis Pharmaceuticals Market
16. Cannabis Pharmaceuticals Market in Texas
17. Competitive Landscape
17.1. FPNV positioning matrix
17.1.1. Quadrants
17.1.2. Business strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market share analysis, by key player
17.4. Competitive scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, collaboration and partnership
17.4.3. Launching and improving new products
17.4.4. Investment & Financing
17.4.5. Reward, recognition and expansion
18. Company Usability Profiles
For more information on this report, visit https://www.researchandmarkets.com/r/nh7gtr
#United #States #Cannabis #Pharmaceuticals #Market #Research #Report #ResearchAndMarketscom
